Stock AECLY AECI LTD
Add to a list
To use this feature you must be a member
Log inSign up

Ratings AECI Ltd OTC Markets

Equities

AECLY

US0010122028

Market Closed - OTC Markets
Other stock markets
 01:10:00 29/11/2023 GMT 		5-day change 1st Jan Change
7.9 USD -.--% Intraday chart for AECI Ltd -.--% -.--%
02-28 Transcript : AECI Ltd, 2023 Earnings Call, Feb 28, 2024
02-27 AECI Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The company's profit outlook over the next few years is a strong asset.
  • Its low valuation, with P/E ratio at 6.64 and 5.19 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The company shows low valuation levels, with an enterprise value at 0.22 times its sales.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • The company is one of the best yield companies with high dividend expectations.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.

Weaknesses

  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Specialty Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
AECI LTD Stock AECI Ltd
-.--% 548M -
ECOLAB INC. Stock Ecolab Inc.
+16.84% 66.69B
A-
SIKA AG Stock Sika AG
+1.79% 49.2B
A-
GIVAUDAN SA Stock Givaudan SA
+17.80% 41.24B
B+
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+20.17% 25.89B
A-
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+12.56% 19.81B
C+
CELANESE CORPORATION Stock Celanese Corporation
+3.13% 17.11B
B+
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-23.12% 15.86B
A-
SYMRISE AG Stock Symrise AG
+2.62% 15.35B
B+
ALBEMARLE CORPORATION Stock Albemarle Corporation
-8.98% 15.23B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. AFE Stock
  4. AECLY Stock
  5. Ratings AECI Ltd